In a release, the Company noted event details:
The announcement will be followed by a live webcast at 5 p.m. EDT/ 2 p.m. PDT, in which Exelixis management will discuss the results and provide a general business update. The webcast may be accessed in the Event Calendar page under Investors at exelixis.com.
An audio replay of the webcast will be available until 11:59 p.m EST/ 8:59 p.m. PST on November 29. Access numbers for the replay are: 1-888-286-8010 (domestic) and 1-617-801-6888 (international), and the passcode is 60917398.
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index